Biocomputer that fuses biology and engineering stemmed from Ignite programme
A participant in the Ignite programme at the Entrepreneurship Centre at Cambridge Judge Business School co-founded BiologIC, a venture that seeks to make the development of gene therapies more affordable. Nick Rollings, an engineer whose previous career included designing a…
Who won at the Cambridge Independent Science and Technology Awards?
Several firms connected to Cambridge Judge Business School are honoured at the Cambridge Independent Science and Technology Awards. Bruno Cotta The Cambridge Independent Science and Technology Awards 2021-22 honoured several firms connected with Cambridge Judge Business School at a ceremony on 11…
India Education Diary: New book highlights how small biotech companies are outperforming big pharma
From Breakthrough to Blockbuster: The Business of Biotechnology, a new book co-authored by Nektarios Oraiopoulos, Associate Professor at Cambridge Judge Business School, shows how small, inexperienced entrepreneurial companies making up the biotech industry have created more life-changing medicines than all…
Venturing forth: bit.bio – reprogramming stem cells to allow manufacture of human cells
Biotech firm bit.bio, which was on the Accelerate Cambridge programme at Cambridge Judge Business School, reprograms stem cells to allow manufacture of human cells. Mark Kotter Mark Kotter, a University of Cambridge stem cell biologist and neurosurgeon who founded biotech…
From Breakthrough to Blockbuster
New book co-authored by Nektarios Oraiopoulos of Cambridge Judge Business School charts the rise of entrepreneurial biotech firms. Dr Nektarios Oraiopoulos From Breakthrough to Blockbuster: The Business of Biotechnology, published today, shows how the small, inexperienced entrepreneurial companies making up…
New board role for Cambridge EMBA alumna
Executive MBA (EMBA) alumna Dr Bola Grace reflects on her appointment to the board of Levin Sources, in the minerals sector. She explains how her education and career so far have led her to the role, offering advice to other…
Forbes: Can we recreate every human cell type in the body? This UK startup thinks so
An interview with Mark Kotter, the founder and CEO of Bit Bio biotechnology company. Bit Bio aims to develop a scalable technology platform capable of producing consistent batches of every human cell. The startup is supported by the Accelerate Cambridge…
Women biotech leaders
Dr Rebecca Myers of the Entrepreneurship Centre at Cambridge Judge is included in the Movers and Shakers in BioBusiness 2020 report by the BioBeat project. Dr Rebecca Myers, Head of Education at the Entrepreneurship Centre of Cambridge Judge Business School,…
Biotech vs big pharma
Most approved "priority" medicines are developed by biotech rather than large pharmaceutical firms, says a two-decade study at the University of Cambridge Judge Business School. Biotech companies created 40 per cent more US Food & Drug Administration-approved "priority" drugs than…
Growth recognition
Cambridge Healthcare Research, co-founded by Cambridge MBA alumnus Max Rubin (MBA 2010), awarded Queen's Award for Enterprise. Cambridge Healthcare Research Ltd, a firm whose Founding Partner is Cambridge MBA graduate Max Rubin (MBA 2010), was awarded a Queen's Award for…
